FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4322626612> ?p ?o ?g. }

• W4322626612 abstract "Rheumatoid arthritis (RA) is a chronic inflammatory autoimmune disease that may lead to bone erosion and disability. Although there are many biological therapies in RA treatment nowadays, such as etanercept and tofacitinib, there are still a considerable number of patients who cannot achieve clinical deep remission, which makes patients feel pain and stiffness of joints. As a traditional Chinese medicine preparation, Wangbi granule showed a synergistic role with methotrexate in the treatment of RA patients with kidney deficiency and dampness or stasis blocking channels. Therefore, it is a promising therapeutic strategy for the clinical deep remission of RA. In this study, Wangbi granule will be used as the test drug. The investigators conduct this study to evaluate the efficacy and safety of Wangbi granule in the treatment of patients who have not achieved deep remission despite the use of methotrexate and tofacitinib.Two parallel randomized, triple-blind, placebo-controlled trials will be conducted. In six study centers, 340 eligible RA patients will be recruited and randomly allocated to either the intervention group or the control group (in a 1:1 ratio). They will receive Wangbi granule or Wangbi placebo 12.0 g each time, three times a day for 12 weeks. The primary outcome is the disease activity score derivative for 28 joints (DAS28). Secondary outcomes are patient-reported outcomes, American College of Rheumatology 50% response criteria (ACR50), fatigue scale-14 (FS-14), visual analogue scale for pain (VAS), health assessment questionnaire disability index (HAQ-DI) and biomarkers such as C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR).The success of this study will provide strong evidence to confirm the efficacy and safety of Wangbi granule in the treatment of RA. Trial registration The trial has been registered in the ClinicalTrials Registry (NCT05540938, Date: 09/15/2022, https://clinicaltrials.gov/ct2/show/NCT05540938 )." @default.
• W4322626612 created "2023-03-01" @default.
• W4322626612 creator A5009318195 @default.
• W4322626612 creator A5016752102 @default.
• W4322626612 creator A5017774638 @default.
• W4322626612 creator A5018200494 @default.
• W4322626612 creator A5035886806 @default.
• W4322626612 creator A5038711316 @default.
• W4322626612 creator A5040787856 @default.
• W4322626612 creator A5053804518 @default.
• W4322626612 creator A5057522977 @default.
• W4322626612 creator A5059300419 @default.
• W4322626612 creator A5062533927 @default.
• W4322626612 creator A5065577170 @default.
• W4322626612 creator A5069923266 @default.
• W4322626612 creator A5072015275 @default.
• W4322626612 date "2023-02-28" @default.
• W4322626612 modified "2023-10-08" @default.
• W4322626612 title "Wangbi granule as a combination therapy to achieve clinical deep remission in rheumatoid arthritis: protocol for a multicenter, triple-blind, randomised, placebo-controlled trial" @default.
• W4322626612 cites W1493918286 @default.
• W4322626612 cites W1608831349 @default.
• W4322626612 cites W2047400624 @default.
• W4322626612 cites W2052912923 @default.
• W4322626612 cites W2108696783 @default.
• W4322626612 cites W2110826367 @default.
• W4322626612 cites W2128952811 @default.
• W4322626612 cites W2152348310 @default.
• W4322626612 cites W2166023752 @default.
• W4322626612 cites W2315394641 @default.
• W4322626612 cites W2593486984 @default.
• W4322626612 cites W2622000437 @default.
• W4322626612 cites W2626892937 @default.
• W4322626612 cites W2765982672 @default.
• W4322626612 cites W2801943566 @default.
• W4322626612 cites W2901023217 @default.
• W4322626612 cites W2943463540 @default.
• W4322626612 cites W3023241482 @default.
• W4322626612 cites W3044289975 @default.
• W4322626612 cites W3154805332 @default.
• W4322626612 cites W3175495335 @default.
• W4322626612 cites W3179165217 @default.
• W4322626612 cites W3194546323 @default.
• W4322626612 cites W3203997342 @default.
• W4322626612 cites W3207122213 @default.
• W4322626612 cites W3209722108 @default.
• W4322626612 cites W4236805817 @default.
• W4322626612 doi "https://doi.org/10.1186/s13020-023-00728-6" @default.
• W4322626612 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36855169" @default.
• W4322626612 hasPublicationYear "2023" @default.
• W4322626612 type Work @default.
• W4322626612 citedByCount "0" @default.
• W4322626612 crossrefType "journal-article" @default.
• W4322626612 hasAuthorship W4322626612A5009318195 @default.
• W4322626612 hasAuthorship W4322626612A5016752102 @default.
• W4322626612 hasAuthorship W4322626612A5017774638 @default.
• W4322626612 hasAuthorship W4322626612A5018200494 @default.
• W4322626612 hasAuthorship W4322626612A5035886806 @default.
• W4322626612 hasAuthorship W4322626612A5038711316 @default.
• W4322626612 hasAuthorship W4322626612A5040787856 @default.
• W4322626612 hasAuthorship W4322626612A5053804518 @default.
• W4322626612 hasAuthorship W4322626612A5057522977 @default.
• W4322626612 hasAuthorship W4322626612A5059300419 @default.
• W4322626612 hasAuthorship W4322626612A5062533927 @default.
• W4322626612 hasAuthorship W4322626612A5065577170 @default.
• W4322626612 hasAuthorship W4322626612A5069923266 @default.
• W4322626612 hasAuthorship W4322626612A5072015275 @default.
• W4322626612 hasBestOaLocation W43226266121 @default.
• W4322626612 hasConcept C126322002 @default.
• W4322626612 hasConcept C14184104 @default.
• W4322626612 hasConcept C142724271 @default.
• W4322626612 hasConcept C168563851 @default.
• W4322626612 hasConcept C1862650 @default.
• W4322626612 hasConcept C198451711 @default.
• W4322626612 hasConcept C204787440 @default.
• W4322626612 hasConcept C27081682 @default.
• W4322626612 hasConcept C2777226972 @default.
• W4322626612 hasConcept C2777575956 @default.
• W4322626612 hasConcept C2778886723 @default.
• W4322626612 hasConcept C2779123688 @default.
• W4322626612 hasConcept C2779134260 @default.
• W4322626612 hasConcept C2781059491 @default.
• W4322626612 hasConcept C3008058167 @default.
• W4322626612 hasConcept C524204448 @default.
• W4322626612 hasConcept C535046627 @default.
• W4322626612 hasConcept C71924100 @default.
• W4322626612 hasConceptScore W4322626612C126322002 @default.
• W4322626612 hasConceptScore W4322626612C14184104 @default.
• W4322626612 hasConceptScore W4322626612C142724271 @default.
• W4322626612 hasConceptScore W4322626612C168563851 @default.
• W4322626612 hasConceptScore W4322626612C1862650 @default.
• W4322626612 hasConceptScore W4322626612C198451711 @default.
• W4322626612 hasConceptScore W4322626612C204787440 @default.
• W4322626612 hasConceptScore W4322626612C27081682 @default.
• W4322626612 hasConceptScore W4322626612C2777226972 @default.
• W4322626612 hasConceptScore W4322626612C2777575956 @default.
• W4322626612 hasConceptScore W4322626612C2778886723 @default.
• W4322626612 hasConceptScore W4322626612C2779123688 @default.
• W4322626612 hasConceptScore W4322626612C2779134260 @default.
• W4322626612 hasConceptScore W4322626612C2781059491 @default.
• W4322626612 hasConceptScore W4322626612C3008058167 @default.

• next